Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

被引：0
|
作者：
Kara N. Maxwell
Danielle Soucier-Ernst
Emin Tahirovic
Andrea B. Troxel
Candace Clark
Michael Feldman
Christopher Colameco
Bijal Kakrecha
Melissa Langer
David Lieberman
Jennifer J. D. Morrissette
Matt R. Paul
Tien-chi Pan
Stephanie Yee
Natalie Shih
Erica Carpenter
Lewis A. Chodosh
Angela DeMichele
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine, Division of Hematology
[2] Perelman School of Medicine at the University of Pennsylvania,Oncology
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology
[5] Perelman School of Medicine at the University of Pennsylvania,Department of Pathology and Laboratory Medicine
[6] Diabetes and Metabolism at the Perelman School of Medicine at the University of Pennsylvania,Department of Cancer Biology
[7] NYU School of Medicine,Department of Medicine, Division of Endocrinology
[8] University of Maryland School of Medicine,Department of Population Health
来源：
Breast Cancer Research and Treatment | 2017年 / 164卷
关键词：
Metastatic breast cancer; Liquid biopsy; Cell-free DNA; Genomic testing; Massively parallel sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 638
页数：11
相关论文
共 50 条
  • [41] Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
    Schwarzenbach, Heidi
    Pantel, Klaus
    Kemper, Birthe
    Beeger, Cord
    Otterbach, Friedrich
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    BREAST CANCER RESEARCH, 2009, 11 (05):
  • [42] Genomic analysis of plasma cell-free DNA in patients with heavily pretreated HER-2+metastatic breast cancer (MBC)
    Lee, K.
    Lee, J.
    Choi, J.
    Sim, S. H.
    Kim, J. E.
    Kim, M. H.
    Park, Y. H.
    Kim, J. H.
    Koh, S.
    Park, K. H.
    Kang, M. J.
    Ahn, M. S.
    Lee, K-E.
    Kim, H. J.
    Ahn, H.
    Kim, H. J.
    Park, K. U.
    Park, I. H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S647 - S647
  • [43] Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients enrolled in the German registry study PRAEGNANT
    Hubner, Hanna
    Wimberger, Pauline
    Laakmann, Elena
    Ruckhaberle, Eugen
    Ruebner, Matthias
    Link, Theresa
    Belleville, Erik
    Faull, Iris
    Hausch, Marcus
    Wallwiener, Diethelm
    Schneeweiss, Andreas
    Tesch, Hans
    Brucker, Sara
    Fasching, Peter A.
    Muller, Volkmar
    Fehm, Tanja
    CANCER RESEARCH, 2024, 84 (09)
  • [44] Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission
    Hunter, Natasha
    Croessmann, Sarah
    Cravero, Karen
    Shinn, Daniel
    Hurley, Paula J.
    Park, Ben Ho
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (04): : 375 - +
  • [45] Genomic diversity between primary tumor tissue and tumor circulating cell-free DNA (cfDNA) in patients (pts) with metastatic prostate cancer.
    Carroll, Emma
    Gill, David Michael
    Poole, Austin
    Hahn, Andrew W.
    Bailey, Erin B.
    Streeter, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [46] Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
    Xiaoran Liu
    Andrew A. Davis
    Feng Xie
    Xinyu Gui
    Yifei Chen
    Qiang Zhang
    Lorenzo Gerratana
    Youbin Zhang
    Ami N. Shah
    Amir Behdad
    Firas Wehbe
    Yong Huang
    Jianjun Yu
    Pan Du
    Shidong Jia
    Huiping Li
    Massimo Cristofanilli
    Breast Cancer Research and Treatment, 2021, 190 : 213 - 226
  • [47] Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
    Liu, Xiaoran
    Davis, Andrew A.
    Xie, Feng
    Gui, Xinyu
    Chen, Yifei
    Zhang, Qiang
    Gerratana, Lorenzo
    Zhang, Youbin
    Shah, Ami N.
    Behdad, Amir
    Wehbe, Firas
    Huang, Yong
    Yu, Jianjun
    Du, Pan
    Jia, Shidong
    Li, Huiping
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (02) : 213 - 226
  • [48] Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach
    Xi, Jing
    Ma, Cynthia X.
    O'Shaughnessy, Joyce
    JCO ONCOLOGY PRACTICE, 2024, 20 (11)
  • [49] Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer
    Roma, L.
    Hench, Bratic, I
    Conticelli, F.
    Bubendorf, L.
    Calgua, B.
    Le Magnen, C.
    Piscuoglio, S.
    Rubin, M.
    Chirindel, A.
    Nicolas, G. P.
    Vlajnic, T.
    Zellweger, T.
    Templeton, A. J.
    Stenner, F.
    Ruiz, C.
    Rentsch, C.
    Bubendorf, L.
    EUROPEAN UROLOGY, 2024, 85 : S1424 - S1424
  • [50] The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review
    Fussey, Jonathan M.
    Bryant, Jennifer L.
    Batis, Nikolaos
    Spruce, Rachael J.
    Hartley, Andrew
    Good, James S.
    McCabe, Christopher J.
    Boelaert, Kristien
    Sharma, Neil
    Mehanna, Hisham
    FRONTIERS IN ONCOLOGY, 2018, 8
12345